[{"Assets_0_Q3_USD":8701215000.0,"EarningsPerShareBasic_1_Q3_USD":3.64,"EarningsPerShareBasic_3_Q3_USD":9.66,"EarningsPerShareDiluted_1_Q3_USD":3.32,"EarningsPerShareDiluted_3_Q3_USD":8.84,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":740163000.0,"NetIncomeLoss_1_Q3_USD":388317000.0,"NetIncomeLoss_3_Q3_USD":1024992000.0,"StockholdersEquity_0_Q3_USD":6051593000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":117028000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":115994000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":106706000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":106108000.0,"Ticker":"REGN","CIK":"872589","name":"REGENERON PHARMACEUTICALS INC","OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"77738004554.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20171108"}]